Literature DB >> 23961546

Burden of illness and use of health care services before and after celiac disease diagnosis in children.

Eeva Mattila1, Kalle Kurppa, Anniina Ukkola, Pekka Collin, Heini Huhtala, Leena Forma, Marja-Leena Lähdeaho, Leila Kekkonen, Markku Mäki, Katri Kaukinen.   

Abstract

OBJECTIVES: Prevalence of celiac disease in children is approximately 1%, but most patients remain unrecognized by reason of variable clinical presentation. Undetected patients may have an increased burden of illness and use of health care services because of nonspecific complaints. We investigated these issues prospectively in newly detected patients with celiac disease before and after diagnosis in a large nationwide cohort of children.
METHODS: A validated questionnaire was sent to consecutive families whose children had been diagnosed as having celiac disease within 1 year. The survey contained questions about the use of medical consultations, on-demand drugs, vitamins and herbal products, children's absenteeism from day care or school and, parents' work absenteeism. A follow-up questionnaire was sent after 1 year of receiving a gluten-free diet.
RESULTS: A total of 132 families responded. A total of 44 children were diagnosed because of gastrointestinal and 88 because of extraintestinal symptoms or by risk-group screening. On treatment, outpatient visits to primary health care decreased from a mean of 3.0 to 1.3 visits per year (P < 0.001), the number of hospitalizations from 0.2 to 0.1 (P = 0.008), and antibiotic prescriptions from 1.0 to 0.5/year (P < 0.001). Visits to secondary and tertiary health care increased from 0.6 to 1.4 (P < 0.001), mostly for celiac surveillance. Use of vitamins, micronutrients, and herbal products increased from 7.3 to 10.2 pills per month (P = 0.028).
CONCLUSIONS: Implementation of a gluten-free diet resulted in reduced use of health care services and antibiotic prescriptions in children. Our findings support active case-finding and risk-group screening for celiac disease.

Entities:  

Mesh:

Year:  2013        PMID: 23961546     DOI: 10.1097/mpg.0b013e31828ee55d

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

Review 1.  Support for patients with celiac disease: A literature review.

Authors:  Jonas F Ludvigsson; Tim Card; Paul J Ciclitira; Gillian L Swift; Ikram Nasr; David S Sanders; Carolina Ciacci
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

2.  Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: A prospective nationwide study.

Authors:  Valma Fuchs; Kalle Kurppa; Heini Huhtala; Markku Mäki; Leila Kekkonen; Katri Kaukinen
Journal:  United European Gastroenterol J       Date:  2018-01-08       Impact factor: 4.623

3.  Mass Screening for Celiac Disease: The Autoimmunity Screening for Kids Study.

Authors:  Marisa G Stahl; Cristy Geno Rasmussen; Fran Dong; Kathleen Waugh; Jill M Norris; Judith Baxter; Liping Yu; Andrea K Steck; Brigitte I Frohnert; Edwin Liu; Marian J Rewers
Journal:  Am J Gastroenterol       Date:  2021-01-01       Impact factor: 12.045

4.  Validation of an algorithm to identify children with biopsy-proven celiac disease from within health administrative data: An assessment of health services utilization patterns in Ontario, Canada.

Authors:  Jason Chan; David R Mack; Douglas G Manuel; Nassim Mojaverian; Joseph de Nanassy; Eric I Benchimol
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 5.  Extraintestinal Manifestations of Celiac Disease: Early Detection for Better Long-Term Outcomes.

Authors:  Pilvi Laurikka; Samuli Nurminen; Laura Kivelä; Kalle Kurppa
Journal:  Nutrients       Date:  2018-08-03       Impact factor: 5.717

6.  Assessing the Burden of Illness Associated with Acquired Generalized Hypoactive Sexual Desire Disorder.

Authors:  James A Simon; Amod Athavale; Rahul Ravindranath; Nandini Hadker; Amama Sadiq; Michelle Lim-Watson; Laura Williams; Julie Krop
Journal:  J Womens Health (Larchmt)       Date:  2022-04-26       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.